{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-021513","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.026169+00:00","generated_at":"2026-05-16T22:25:24.375378+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"iMDx reports Q3 2025 net loss of $10.9M, advances toward FDA submission for GraftAssureDx by year-end","bullets":["Revenue $260k from lab services; gross margin 53.5%; net loss $10.9M ($0.34/sh); cash $20.2M.","On track to submit GraftAssureDx for FDA review by year-end; expect mid-2026 commercial launch.","19 transplant centers engaged with GraftAssure technology; goal of 20 by year-end; 11 clinical trial sites.","Operating expenses $11.2M include $3.4M non-cash contingent consideration change; R&D up 18% QoQ to $3.9M.","New VP Marketing Steven Tahmooressi hired; registry study of 5,000 patients planned; expanding into heart transplant testing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-021513","json":"https://secwatch.observer/filing/0001493152-25-021513.json","markdown":"https://secwatch.observer/filing/0001493152-25-021513.md","text":"https://secwatch.observer/filing/0001493152-25-021513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225021513/0001493152-25-021513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225021513/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:25:24.375378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}